Palisade-Heritage JV LLC

Palisade-Heritage JV LLC, a service-disabled veteran-owned small business joint venture based in Valrico, Florida, delivers first-fill pharmacy services, pharmacy benefit management, and pharmaceutical administration to the Department of Veterans Affairs across multiple regional networks as a prime contractor operating at scale and profitability, competing across both set-aside and full-and-open procurements.

Palisade-Heritage is structured as a for-profit limited liability company with formal SBA certifications as a Service-Disabled Veteran-Owned Small Business (SDVOSB) and self-certified designation as a small disadvantaged business. The vendor's federal footprint is singular and concentrated: 213 recent prime awards carry a combined potential value of $73.1 million, with $21.3 million obligated (29% utilization), spanning fourteen distinct federal agencies but anchored almost entirely in the Veterans Health Administration. Five VISNs account for 77 percent of recent award volume — VISN 4 leads with 54 awards and $12.7 million potential value, followed by VISN 20 (39 awards, $9.8 million), VISN 5 (31 awards, $10.9 million), VISN 1 (22 awards, $14.9 million), and VISN 17 (17 awards, $2.8 million). Dollar ranking differs marginally: VISN 1 anchors potential value at $14.9 million, suggesting larger individual delivery orders despite lower award count.

The capability portfolio is tightly scoped to pharmacy execution. Recent representative work includes a $5.5 million single-award IDC with VISN 9 for pharmacy benefits management and emergency pharmaceutical services (December 2022, extending through September 2032); a $7 million BPA with VISN 20 for third-party first-fill pharmacy services across the Pacific Northwest (April 2022 through March 2027); a $2 million single-award IDC with VISN 16 for first-fill pharmacy and medication counseling services (April 2022 through March 2027); a $2.2 million purchase order with VA Strategic Acquisition Center Frederick for pharmacy benefits management under the Camp Lejeune Family Member Program (April 2022 through April 2027); and a $1.3 million purchase order with VISN 23 for first-fill pharmacy services in Minnesota and Wisconsin (April 2023 through March 2028). Delivery orders under these parent vehicles range from $3,000 to $412,000 and address emergency prescription fulfillment, routine prescription dispensing, medication counseling, pharmacy benefit administration, third-party prescription fulfillment, sterile compounding, and after-hours pharmacy support. Work is performed at VA medical centers and community-based outpatient clinics across domestic locations (Valrico, Mountain Home, Tennessee; Asheville, North Carolina; Portland, Oregon; El Paso, Texas; Aurora, Colorado; and multiple Pennsylvania and Texas sites). Top NAICS coding reflects pharmacy services focus: Pharmacy Benefit Management and Other Third Party Administration (96 awards); Offices of All Other Miscellaneous Health Practitioners (54); and Payroll Services (32). PSC coding centers on Pharmacy Services (138 awards).

Recent activity shows contraction. Palisade-Heritage awarded 50 contracts in 2022, declining to 42 in 2023, 31 in 2024, and 33 in 2025, with only 14 awards so far in 2026 (year-to-date as of October). This trajectory suggests either a base-period wind-down or declining reorder velocity on existing vehicles. Twenty-four awards totaling $10 million in combined potential value carry ultimate completion dates within the next twenty-four months and therefore face recompete exposure; this includes several significant VISN 4, VISN 1, and VISN 5 delivery orders expiring through mid-2027.

Palisade-Heritage operates as a pure prime across its federal footprint (100 percent prime awards, zero sub-awards). Across SCI-reportable federal service contracts (which capture invoiced revenue and labor above the $150,000 threshold), the vendor delivered $4.3 million in combined invoiced revenue spanning fiscal years 2023–2025 ($1.2 million FY2023, $1.9 million FY2024, $1.2 million FY2025). SCI-reported FTE scale remained modest: 0.7 FTEs in FY2023, peaked at 0.8 in FY2024, and contracted to 0.1 in FY2025, suggesting significant portion of pharmacy work is structured as firm-fixed-price delivery orders with minimal on-site labor reporting. The vendor self-performs all reported contract hours with zero subcontractor engagement across SCI prime records. Government-paid hourly rate posture on SCI contracts spans from $227/hour (tenth percentile) to $2,997/hour (ninetieth percentile), with a median of $855/hour, reflecting mix of administrative and clinical pharmacy labor. Parent contract vehicles dominate task-order activity: BPA 36C26022A0014 carries 68 calls and $6.6 million combined value; IDC 36C24420D0073 holds 53 calls and $4.7 million; BPA 36C24521A0039 supports 30 calls and $3.9 million; and IDC 36C24118D0074 anchors 21 calls and $8 million. Set-aside posture splits between SDVOSB-reserved awards and full-and-open competition; most recent awards (FY2025 forward) show increasing proportion of full-and-open delivery orders alongside SDVOSB set-aside calls, indicating the vendor competes across both categories and does not rely exclusively on its veteran-owned status.